Showing results (21-30 of 222) with videos related to
Sort By:
Pageof 23
Drug Safety|January 27, 2000
A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosisA K Gupta, N H ShearJournal of the European Academy of Dermatology and Venereology : JEADV|November 24, 1999
The new oral antifungal agents for onychomycosis of the toenailsA K Gupta, N H ShearArchives of Dermatology|August 1, 1995
Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?N H Shear, A K GuptaInternational Journal of Dermatology|July 1, 1998
A questionnaire study on the management of onychomycosis: a Canadian perspectiveA K Gupta, N H ShearThe Journal of Clinical Investigation|December 1, 1988
Anticonvulsant hypersensitivity syndrome. In vitro assessment of riskN H Shear, S P SpielbergCMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 3, 1999
Utilization of health care resources by obese CanadiansK Trakas, K Lawrence, N H ShearDrug Safety|March 10, 2001
What will be the role of pharmacogenetics in evaluating drug safety and minimising adverse effects?V Ozdemir, N H Shear, W KalowLancet (London, England)|November 15, 2000
Idiosyncratic drug reactions: the reactive metabolite syndromesS R Knowles, J Uetrecht, N H ShearJournal of Biomechanical Engineering|October 5, 2010
Ballistic impact of single particles into gelatin: experiments and modeling with application to transdermal pharmaceutical deliveryR A Guha, N H Shear, M PapiniArchives of Dermatology|August 1, 1996
Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literatureS R Knowles, L Shapiro, N H ShearPageof 23